EVELIQURE BIOTECHNOLOGIES GMBH
EveliQure was founded in 2012 with headquarters in Vienna and developed for the first time a combined vaccine, which is intended to protect against Shigella as well as against ETEC bacteria. Both bacterial strains cause various types of diarrheal diseases, and all attempts at development of vaccines have so far only aimed to protect against one of the two bacterial strains. The team led by Managing Director Gábor Somogyi has succeeded for the first time in producing a combined swallow vaccine that simultaneously protects against both bacterial strains.
EVELIQURE BIOTECHNOLOGIES GMBH
Social Links:
Industry:
Life Science
Founded:
2012-01-01
Address:
Vienna, Wien, Austria
Country:
Austria
Website Url:
http://www.eveliqure.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
2.82 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Euro Microsoft Exchange Online Office 365 Mail
Similar Organizations
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
SpyBiotech
SpyBiotech Operators of a biotechnology platform intended to generate next-generation vaccines.
Current Employees Featured
Founder
Investors List
Arax Capital Partners
Arax Capital Partners investment in Series A - EveliQure Biotechnologies GmbH
Kinled Holding
Kinled Holding investment in Venture Round - EveliQure Biotechnologies GmbH
Official Site Inspections
http://www.eveliqure.com Semrush global rank: 6.17 M Semrush visits lastest month: 1.31 K
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
